Evidence map›Paper›PMID 40637932›Full record

ArticleJournal of neurology2025

Late-onset cerebellar ataxia in three European patients with repeat expansions in RFC1 and FGF14: a case series.

Armand Hocquel, David Pellerin, Jean Loup Méreaux, Vincent Huin, Marios Hadjivassiliou, Guillemette Clément, Felipe Villa, Salomé Puisieux, Solène Frismand, Marion Wandzel and 17 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Armand HocquelService de Neurologie, Centre Hospitalier Régional Universitaire de Nancy, Nancy, France.ORCID http://orcid.org/0000-0002-1310-7654
David PellerinDepartment of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada.
Jean Loup MéreauxSorbonne Université, Paris Brain Institute - ICM, Inserm, CNRS, AP-HP, Paris, France.
Vincent HuinUniv. Lille, Inserm, CHU Lille, U1172 - LilNCog (JPARC) - Lille Neuroscience & Cognition, 59000, Lille, France.
Marios HadjivassiliouAcademic Department of Neurosciences, Sheffield Teaching Hospitals NHS Trust and University of Sheffield, Sheffield, UK.
Guillemette ClémentService de Neurologie, Centre Hospitalier Régional Universitaire de Nancy, Nancy, France.
Felipe VillaDepartment of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada.
Salomé PuisieuxService de Neurologie, Centre Hospitalier Régional Universitaire de Nancy, Nancy, France.
Solène FrismandService de Neurologie, Centre Hospitalier Régional Universitaire de Nancy, Nancy, France.
Marion WandzelLaboratoire de génétique, Université de Lorraine, CHRU-Nancy, 54000, Nancy, France.
Virginie RothLaboratoire de génétique, Université de Lorraine, CHRU-Nancy, 54000, Nancy, France.
Anna WissocqDepartment of Toxicology and Genopathies, Univ. Lille, Inserm, CHU Lille, UF Neurobiology, 59000, Lille, France.
Thomas WirthService de Neurologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Matt C DanziDr. John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL, USA.
Isabelle QuadrioBiochemistry and Molecular Biology - Neurogenetic Department, Hospices Civils de Lyon, Lyon, France.
Stephan ZuchnerDr. John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL, USA.
Laetitia LambertService de Génétique Clinique, Centre Hospitalier Régional Universitaire de Nancy, Rue du Morvan, 54500, Vandoeuvre-lès-Nancy, France.
Fanny MochelSorbonne Université, Paris Brain Institute - ICM, Inserm, CNRS, AP-HP, Paris, France.
Matthis SynofzikDivision Translational Genomics of Neurodegenerative Diseases, Center for Neurology and Hertie Institute for Clinical Brain Research, Tübingen, Germany.
Mathieu AnheimService de Neurologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Henry HouldenDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology and The National Hospital for Neurology and Neurosurgery, University College London, London, UK.
Alexis BriceSorbonne Université, Paris Brain Institute - ICM, Inserm, CNRS, AP-HP, Paris, France.
Carine PouriéUniversité de Lorraine, Inserm, NGERE, 54000, Nancy, France.
Bernard BraisDepartment of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada.
Céline BonnetLaboratoire de génétique, Université de Lorraine, CHRU-Nancy, 54000, Nancy, France.
Alexandra DurrSorbonne Université, Paris Brain Institute - ICM, Inserm, CNRS, AP-HP, Paris, France.
Mathilde RenaudService de Neurologie, Centre Hospitalier Régional Universitaire de Nancy, Nancy, France. m.renaud2@chru-nancy.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40637932

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.